Figure 3From: Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer Comparison of PFS (a) and OS (b) between PR and SD. PR partial response; SD stable disease; PFS progression-free survival; OS overall survival.Back to article page